Timothy G Berger: Influence Statistics

Timothy G Berger

Timothy G Berger

Department of Dermatology, University of California, San Francisco, California, USA | 3University of California at San Francisco, San Francisco, CA, USA | Department of ...


Download all Influence Scores

Timothy G Berger: Expert Impact

Concepts for which Timothy G Berger has direct influence: Bacillary angiomatosis , Atopic dermatitis , Human immunodeficiency virus , Human papillomavirus , Hiv infection , Skin cancer , Herpes simplex virus .

Timothy G Berger: KOL impact

Concepts related to the work of other authors for which for which Timothy G Berger has influence: Atopic dermatitis , Bacillary angiomatosis , Hiv infection , Bartonella henselae , Skin cancer , Kaposi sarcoma , Scratch disease .

KOL Resume for Timothy G Berger

Year
2021

Department of Dermatology, University of California, San Francisco, California, USA

2020

Department of Dermatology, University of California, San Francisco

2019

Department of Dermatology, University of California, San Francisco, San Francisco, CA, United States.

2017

Department of Dermatology, University of California San Francisco, San Francisco, CA, USA

2016

Department of Dermatology, University of California, San Francisco, School of Medicine, San Francisco, California

2015

School of Medicine University of California Department of Dermatology San Francisco CA USA

Department of Dermatology, University of California San Francisco

2014

Department of Dermatology, University of California San Francisco, San Francisco, California

2013

Department of Dermatology, University of California, San Francisco, San Francisco, CA, United States

2012

Department of Dermatology, University of California–San Francisco, San Francisco, California

2011

Department of Dermatology, University of California San Francisco, San Francisco, CA 94143, USA.

2010

Department of Dermatology at the University of California, San Francisco, San Francisco, California

2009

Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA

2008

Department of Dermatology, University of California, San Francisco, San Francisco, California.

2006

Department of Dermatology, University of California, San Francisco, California, USA.

2005

Departments of Dermatology

University of California, San Francisco and

2004

From the Department of Dermatology, University of California, San Francisco

2002

Department of Dermatology, University of California, San Francisco, California, USA, US

2001

From the WIHS Collaborative Study Group; University of California, San Franciscoa; University of Southern California, Los Angelesb; Mt Sinai Medical Center, New Yorkc; Cook County Hospital, Chicagod; Georgetown University Medical Center, Washingtone; State University of New York Health Science Center at Brooklynf; and Johns Hopkins School of Hygiene and Public Health, Baltimore.g

San Francisco and Los Angeles, California; New York and Brooklyn, New York; Chicago, Illinois; Washington, DC; and Baltimore, Maryland

2000

the Department of Dermatology, San Francisco General Hospital, San Francisco, California, USA

University of California Department of Dermatology San Francisco U.S.A.

1999

San Francisco, California

1998

Departments of Dermatology, University of California, San Francisco, CA, USA

1997

From the Departments of Medicine (J.E.K., C.S.G.), Dermatology (M.J.W., T.G.B., P.E.L., J.W.T.), and Pathology (P.E.L.), University of California, San Francisco

1996

University of California, San Francisco, 400 Parnassus, Box 0316, 94143, San Francisco, CA

the Dermatology Service, San Francisco General Hospital, San Francisco, California, USA

1995

Department of Dermatology, San Francisco General Hospital, San Francisco, California, USA.

1994

Department of Dermatology, University of California, San Francisco.

San Francisco, California, USA

1993

Department of Dermatology, University of California School of Medicine, San Francisco, CA, USA

1992

Dermatology Service, Department of Medicine, Letterman Army Medical Center, Presidio, San Francisco, California USA

1991

Chief, Department of Dermatology, San Francisco General Hospital; and Assistant Clinical Professor of Dermatology, University of California, San Francisco, San Francisco, California

1989

Departments of Pathology (P.E.L., B.M.E., J.H.B., T.S.B.Y.), Dermatology (P.E.L., T.G.B., B.M.E.), and Laboratory Medicine (J.H.B.), School of Medicine, University of California, San Francisco, California; the Section of Dermatology, San Francisco General Hospital (T.G.B.); and the Department of Pathology and Laboratory Medicine, School of Medicine and Dentistry, University of Rochester, Rochester, New York (M.H.S.).

Department of Dermatology, San Francisco General Hospital, CA.

San Francisco General Hospital San Francisco, CA 94110, USA

1988

From the Dermatology Service, Department of Medicine, Letterman Army Medical Center, Presidio of San Francisco

1987

From the Dermatology Service Department of Medicine, Letterman Army Medical Center, Presidlo of San Francisco, CA

San Francisco, USA

Dermatology Service, Department of Medicine, Letterman Army Medical Center, U.S.A.

1986

Dermatology Service, Department of Medicine, Letterman Army Medical Center, Presidio of San Francisco, California

1985

the Dermatology Service, Letterman Anny Medical Center, Presidio of San Francisco, CA

1984

Armed Forces Institute of Pathology and the Veterans Administration Special Reference Laboratory for Pathology, Washington, DC

San Francisco, CA, USA

Prominent publications by Timothy G Berger

KOL-Index: 18485 . An association between erythema multiforme and herpes simplex virus infection has been supported by clinical studies and by the detection by immunofluorescence of herpes viral antigen in sera and skin biopsy specimens of patients with erythema multiforme. In rare cases, the virus has also been isolated in cultures of skin biopsy specimens of erythema multiforme. To investigate further the ...
Known for Simplex Virus | Erythema Multiforme | Polymerase Chain Reaction | Viral Dna
KOL-Index: 9769 . The appropriate use criteria process synthesizes evidence-based medicine, clinical practice experience, and expert judgment. The American Academy of Dermatology in collaboration with the American College of Mohs Surgery, the American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery has developed appropriate use criteria for 270 scenarios for which ...
Known for Mohs Surgery | Situ Carcinoma | Dermatology College | Basal Cell
KOL-Index: 9765 . BACKGROUND: Bacillary angiomatosis and bacillary peliosis are vascular proliferative manifestations of infection with species of the genus bartonella that occur predominantly in patients infected with the human immunodeficiency virus. Two species, B. henselae and B. quintana, have been associated with bacillary angiomatosis, but culture and speciation are difficult, and there has been ...
Known for Molecular Epidemiology | Bartonella Infections | Henselae Quintana | Patients Bacillary Angiomatosis
KOL-Index: 9021 . BACKGROUND: Bacillary angiomatosis is characterized by vascular lesions, which occur usually in patients infected with the human immunodeficiency virus (HIV). A newly described gram-negative organism, Rochalimaea henselae, has been associated with cutaneous bacillary angiomatosis, but no organism has been isolated and cultivated directly from cutaneous tissue. METHODS: We used two methods ...
Known for Bacillary Angiomatosis | Rochalimaea Species | Patients Quintana | Cutaneous Lesions
KOL-Index: 8931 . IntroductionIntense nocturnal pruritus as well as the complex pathophysiology of atopic dermatitis (AD) can severely affect sleep and become a major factor in negatively impacting quality of life in adults. However, much of the literature on sleep disturbance in AD patients is on the pediatric population, and it is not well studied in adults. Furthermore, limited studies are available to ...
Known for Sleep Disturbance | Adults Atopic Dermatitis | Major Factor | Effective Management
KOL-Index: 7746 . Objective: To examine risk factors for the development of cutaneous squamous cell carcinoma (SCC) in a group of human immunodeficiency virus (HIV)— infected patients, including evaluation and detection of epidemiologic risk factors of human papillomavirus (HPV) and p53 expression.Design: Case-control study during a 3-year period.Setting: Dermatologic referral center.Patients: Thirty-three ...
Known for Human Papillomavirus | Cell Carcinoma | Hivinfected Patients | Immunodeficiency Virus
KOL-Index: 7586 . Background and Design: This study determines (1) the readiness of primary care physicians (PCPs) to triage optimally lesions suspicious for skin cancer, (2) the difference in their abilities from those of dermatologists, and (3) whether accurate diagnosis after viewing slide images transfers to accurate diagnosis after viewing lesions on patients. Seventy-one primary care residents and 15 ...
Known for Skin Cancer | Primary Residents | Accurate Diagnosis | Malignant Melanomas
KOL-Index: 7484 . OBJECTIVE: To evaluate safety and efficacy of thalidomide in the treatment of prurigo nodularis in a group of human immunodeficiency virus (HIV)-infected patients whose condition was recalcitrant to standard treatment. DESIGN: Prospective study. SETTING: Outpatient dermatology and neurology clinic, both referral settings. PATIENTS: Eight HIV-infected patients with refractory prurigo ...
Known for Prurigo Nodularis | Thalidomide Treatment | Human Immunodeficiency Virus | Peripheral Neuropathy
KOL-Index: 7360 . Certain skin cancers occur with increased frequency or altered course in patients infected with HIV. Malignant melanoma and squamous cell carcinoma are examples of cutaneous malignancies that have a more aggressive course in patients with HIV. Others, such as basal cell carcinoma, appear more frequently in this population but do not appear to be more aggressive. The incidence of ...
Known for Cutaneous Malignancy | Anaplastic Lymphoma | Basal Cell Carcinoma | Patients Hiv
KOL-Index: 7269 . The acquired immunodeficiency syndrome (AIDS) epidemic has had a profound impact on our understanding of Kaposi's sarcoma (KS). Epidemiologic features suggest a sexually transmitted cofactor in the pathogenesis of AIDS-associated KS (AIDS-KS), and several putative agents have received intense scrutiny. Cell culture studies suggest that the angiogenesis of AIDS-KS is stimulated by both ...
Known for Clinical Spectrum | Ks Patients | Local Therapy | Sarcoma Kaposi

Key People For Bacillary Angiomatosis

Top KOLs in the world
#1
Jane E Koehler
bacillary angiomatosis bartonella henselae domestic cats
#2
Philip E LeBoit
mycosis fungoides bacillary angiomatosis situ hybridization
#3
Timothy G Berger
bacillary angiomatosis atopic dermatitis human immunodeficiency virus
#4
Jordan W Tappero
antiretroviral therapy bacillary angiomatosis hiv infection
#5
Mark H Stoler
human papillomavirus situ hybridization cervical cancer
#6
Roy T Steigbigel
lymph nodes human immunodeficiency virus albumin synthesis

Department of Dermatology, University of California, San Francisco, California, USA | 3University of California at San Francisco, San Francisco, CA, USA | Department of Dermatology, University of California, San Francisco | Department of Dermatology,